1. Home
  2. FEIM vs ARVN Comparison

FEIM vs ARVN Comparison

Compare FEIM & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frequency Electronics Inc.

FEIM

Frequency Electronics Inc.

N/A

Current Price

$60.46

Market Cap

722.9M

Sector

Industrials

ML Signal

N/A

Logo Arvinas Inc.

ARVN

Arvinas Inc.

N/A

Current Price

$9.18

Market Cap

600.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FEIM
ARVN
Founded
1961
2015
Country
United States
United States
Employees
N/A
246
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
722.9M
600.2M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
FEIM
ARVN
Price
$60.46
$9.18
Analyst Decision
Buy
Buy
Analyst Count
2
19
Target Price
$51.50
$15.05
AVG Volume (30 Days)
228.0K
871.4K
Earning Date
03-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
1.70
Revenue
$63,227,000.00
$262,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$21.73
N/A
P/E Ratio
N/A
$5.44
Revenue Growth
N/A
N/A
52 Week Low
$26.05
$6.97
52 Week High
$80.60
$14.22

Technical Indicators

Market Signals
Indicator
FEIM
ARVN
Relative Strength Index (RSI) 43.61 51.84
Support Level $62.33 $7.90
Resistance Level $64.99 $9.65
Average True Range (ATR) 3.86 0.31
MACD -1.44 -0.02
Stochastic Oscillator 20.33 31.07

Price Performance

Historical Comparison
FEIM
ARVN

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is a world leader in precision time and frequency generation technology, which is incorporated into commercial and U.S. Government satellites, Command, Control, Communication, Computer, Intelligence, Surveillance and Reconnaissance, and Electronic Warfare systems. Its technology is used for a wide range of space and non-space applications. The company has two segments FEI-NY, and FEI-Zyfer. Majority of revenue come from FEI-NY which provides precision time, frequency generation and synchronization products and subsystems that are found on-board satellites, in ground-based communication systems and imbedded in mobile platforms operated by the U.S. military.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: